Novartis AG
Price Action
Technical Summary
STAGE 2 UPTRENDNovartis AG is in a confirmed Stage 2 uptrend, with price holding above all major moving averages and trend structure remaining intact. Relative strength is leading (RS Rating: 82), indicating clear outperformance against the broad market. Earnings contraction of 11% provides fundamental context to the price action. Momentum will need to be maintained above the 50-day moving average to sustain this leadership phase.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $160.19 | +5.26% | ABOVE |
| 50 SMA | $149.34 | +12.91% | ABOVE |
| 100 SMA | $139.44 | +20.93% | ABOVE |
| 150 SMA | $134.19 | +25.66% | ABOVE |
| 200 SMA | $129.90 | +29.81% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is NVS in an uptrend right now?
NVS has a trend score of 4/4 based on Minervini's Stage Analysis. Yes, NVS is in a Stage 2 uptrend with price above all major moving averages (50, 100, 150, 200 SMA) properly stacked.
Is NVS overbought or oversold?
NVS's RSI (14) is 70. The stock is in overbought territory (RSI > 70), which may signal a pullback.
Is NVS outperforming the market?
NVS has a Relative Strength (RS) Rating of 82 out of 99. Yes, NVS is a market leader, outperforming 82% of all stocks over the past 12 months.
Where is NVS in its 52-week range?
NVS is trading at $168.62, which is 99% of its 52-week high ($170.46) and 97% above its 52-week low ($97.72).
How volatile is NVS?
NVS has a Beta of 0.24 and 52-week volatility of 22%. It's less volatile than the S&P 500 - generally more stable.